Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • Compliance
      • Certified Designated Representative Training Courses
      • DEA Compliance
      • DSCSA
      • FDA Reporting
      • NABP Drug Distributor Accreditation (VAWD)
      • Operational Audits
      • Outsourced Quality & Compliance Support
      • Puerto Rico Services
      • State Compliance Services
    • Commercial
      • Business Strategy & Consulting
    • Quality
      • CMO Audit, On-Site Or Remote
      • FDA Preparedness Audit
    • NavigateSOM
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page
NY Pharmacies Unite to Take Aim at PBMs

NY Pharmacies Unite to Take Aim at PBMs

by Five Rivers Rx | Nov 29, 2018 | Competition, Industry News

Earlier this month over 500 independent pharmacy owners came together to launch FixRx. FixRx is a multi-prong campaign to fight the abusive practices of Pharmacy Benefit Managers (PBMs). PBM and Industry Consolidation PBMs manage the “pharmacy-benefit” for insurance...
BREAKING: Members of AIPW Attempt to Reopen Case for Preliminary Injunction Against Optum Rx

BREAKING: Members of AIPW Attempt to Reopen Case for Preliminary Injunction Against Optum Rx

by Five Rivers Rx | Nov 14, 2018 | Industry News, Optum Rx, VAWD

Three members of AIPW (“Movants”) have filed to reopen the case against OptumRx which challenges the validity and legality of OptumRx’s VAWD Accreditation requirement for the suppliers of their network pharmacies. Original Filing, November 2016 The Association of...

Recent Posts

  • NavigateSOM Releases User Manual
  • Retail Pharmacy Headwinds: New Technology & Disruption
  • Five Rivers RX Submits Comments on New PR Rule
  • Maryland to Accept NCDQS Accreditation for Licensing Requirements
  • New Version of the NABP DDA P&P Assessment Released

Archives

  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

 

Subscribe to Our Newsletter